Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-03-20
DOI
10.3389/fneur.2017.00102
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Amyloid-β Toxicity and Tau Hyperphosphorylation are Linked Via RCAN1 in Alzheimer's Disease
- (2018) Ana Lloret et al. JOURNAL OF ALZHEIMERS DISEASE
- Candidate Blood Proteome Markers of Alzheimer's Disease Onset and Progression: A Systematic Review and Replication Study
- (2018) Steven J. Kiddle et al. JOURNAL OF ALZHEIMERS DISEASE
- Plasma Amyloid-β as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging
- (2017) James K. Lui et al. JOURNAL OF ALZHEIMERS DISEASE
- Decreasing the expression of PICALM reduces endocytosis and the activity of β-secretase: implications for Alzheimer’s disease
- (2016) Rhian S. Thomas et al. BMC NEUROSCIENCE
- Toward more predictive genetic mouse models of Alzheimer's disease
- (2016) Kristen D. Onos et al. BRAIN RESEARCH BULLETIN
- The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer’s Disease
- (2016) Ann De Vos et al. JOURNAL OF ALZHEIMERS DISEASE
- TREM2 variants: new keys to decipher Alzheimer disease pathogenesis
- (2016) Marco Colonna et al. NATURE REVIEWS NEUROSCIENCE
- Loss of Bin1 Promotes the Propagation of Tau Pathology
- (2016) Sara Calafate et al. Cell Reports
- Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer’s disease: a systematic review
- (2016) Qingwei Ruan et al. BMC Geriatrics
- Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins
- (2016) N Voyle et al. Translational Psychiatry
- Genetic risk of neurodegenerative diseases is associated with mild cognitive impairment and conversion to dementia
- (2015) Hieab H.H. Adams et al. Alzheimers & Dementia
- A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ 42
- (2015) Kristel Sleegers et al. Alzheimers & Dementia
- Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study
- (2015) Vincent Chouraki et al. Alzheimers & Dementia
- 2015 Alzheimer's disease facts and figures
- (2015) Alzheimers & Dementia
- Screening of dementia genes by whole-exome sequencing in early-onset Alzheimer disease: input and lessons
- (2015) Gaël Nicolas et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- The genetic landscape of Alzheimer disease: clinical implications and perspectives
- (2015) Caroline Van Cauwenberghe et al. GENETICS IN MEDICINE
- TREM2 is associated with increased risk for Alzheimer’s disease in African Americans
- (2015) Sheng Chih Jin et al. Molecular Neurodegeneration
- The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer’s but Not Parkinson’s Disease or Dementia with Lewy Bodies
- (2015) Malin Wennström et al. PLoS One
- Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
- (2015) Konstantin Hellwig et al. Alzheimers Research & Therapy
- Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study
- (2015) Julien Dumurgier et al. Alzheimers Research & Therapy
- Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease
- (2015) Maartje I. Kester et al. JAMA Neurology
- Association of Brain DNA Methylation inSORL1,ABCA7,HLA-DRB5,SLC24A4, andBIN1With Pathological Diagnosis of Alzheimer Disease
- (2015) Lei Yu et al. JAMA Neurology
- Magnetic resonance imaging biomarkers for the early diagnosis of Alzheimer's disease: a machine learning approach
- (2015) Christian Salvatore et al. Frontiers in Neuroscience
- Fluid Biomarkers in Clinical Trials of Alzheimer’s Disease Therapeutics
- (2015) Aaron Ritter et al. Frontiers in Neurology
- Blood-Based Proteomic Biomarkers of Alzheimer’s Disease Pathology
- (2015) Alison L. Baird et al. Frontiers in Neurology
- Tau phosphorylation regulates the interaction between BIN1’s SH3 domain and Tau’s proline-rich domain
- (2015) Yoann Sottejeau et al. Acta Neuropathologica Communications
- Plasma Aβ but Not Tau is Related to Brain PiB Retention in Early Alzheimer’s Disease
- (2014) Kai-Yuan Tzen et al. ACS Chemical Neuroscience
- The critical need for defining preclinical biomarkers in Alzheimer's disease
- (2014) Massimo S. Fiandaca et al. Alzheimers & Dementia
- Plasma proteins predict conversion to dementia from prodromal disease
- (2014) Abdul Hye et al. Alzheimers & Dementia
- Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's disease
- (2014) Katrin Morgen et al. Alzheimers & Dementia
- Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014
- (2014) L. S. Schneider et al. JOURNAL OF INTERNAL MEDICINE
- Differences in Anxiety Among Patients With Early- Versus Late-Onset Alzheimer’s Disease
- (2014) Natalie C. Kaiser et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment
- (2014) L Cheng et al. MOLECULAR PSYCHIATRY
- Plasma phospholipids identify antecedent memory impairment in older adults
- (2014) Mark Mapstone et al. NATURE MEDICINE
- The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
- (2014) Reisa Sperling et al. NEURON
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease
- (2014) A. M. Fagan et al. Science Translational Medicine
- The A4 Study: Stopping AD Before Symptoms Begin?
- (2014) R. A. Sperling et al. Science Translational Medicine
- MicroRNA-34a: a potential therapeutic target in human cancer
- (2014) X J Li et al. Cell Death & Disease
- BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
- (2014) Robert Vassar Alzheimers Research & Therapy
- Synergistic Effect of β-Amyloid and Neurodegeneration on Cognitive Decline in Clinically Normal Individuals
- (2014) Elizabeth C. Mormino et al. JAMA Neurology
- Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma
- (2014) Shephali Bhatnagar et al. Frontiers in Molecular Neuroscience
- Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease
- (2013) Alan Rembach et al. Alzheimers & Dementia
- Genetics of dementia
- (2013) Clement T Loy et al. LANCET
- Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
- (2013) Stephanie JB Vos et al. LANCET NEUROLOGY
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
- (2013) Victor L Villemagne et al. LANCET NEUROLOGY
- Fluid biomarkers in Alzheimer’s disease – current concepts
- (2013) Christoffer Rosén et al. Molecular Neurodegeneration
- Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology
- (2013) J Chapuis et al. MOLECULAR PSYCHIATRY
- A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study
- (2013) S C Burnham et al. MOLECULAR PSYCHIATRY
- Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease
- (2013) Herve Rhinn et al. NATURE
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
- (2013) Jean-Charles Lambert et al. NATURE GENETICS
- Correction: Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
- (2013) Chia-Chen Liu et al. Nature Reviews Neurology
- Validation of next-generation sequencing technologies in genetic diagnosis of dementia
- (2013) John Beck et al. NEUROBIOLOGY OF AGING
- Alzheimer's disease biomarkers: Correspondence between human studies and animal models
- (2013) Jonathan J. Sabbagh et al. NEUROBIOLOGY OF DISEASE
- Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI
- (2013) S. J. B. Vos et al. NEUROLOGY
- Bridging integrator 1 (BIN1): form, function, and Alzheimer's disease
- (2013) Meng-Shan Tan et al. TRENDS IN MOLECULAR MEDICINE
- Clusterin in Alzheimer’s disease: a player in the biological behavior of amyloid-beta
- (2013) Xiang Li et al. Neuroscience Bulletin
- A blood based 12-miRNA signature of Alzheimer disease patients
- (2013) Petra Leidinger et al. GENOME BIOLOGY
- The Role of Clusterin in Amyloid-β–Associated Neurodegeneration
- (2013) Rahul S. Desikan et al. JAMA Neurology
- Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease
- (2013) Gaël Chételat et al. NeuroImage-Clinical
- Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease
- (2012) Henrik Zetterberg ARCHIVES OF NEUROLOGY
- Extracellular Tau Levels Are Influenced by Variability in Tau That Is Associated with Tauopathies
- (2012) Celeste M. Karch et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer’s disease
- (2012) E. Rodríguez-Rodríguez et al. JOURNAL OF NEURAL TRANSMISSION
- Supporting evidence for using biomarkers in the diagnosis of MCI due to AD
- (2012) Samantha Galluzzi et al. JOURNAL OF NEUROLOGY
- The Role of Clusterin in Alzheimer’s Disease: Pathways, Pathogenesis, and Therapy
- (2012) Jin-Tai Yu et al. MOLECULAR NEUROBIOLOGY
- Whole-genome and whole-exome sequencing in neurological diseases
- (2012) Jia-Nee Foo et al. Nature Reviews Neurology
- CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease
- (2012) R. Tarawneh et al. NEUROLOGY
- Variant of TREM2 Associated with the Risk of Alzheimer's Disease
- (2012) Thorlakur Jonsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of a Previously Suggested Plasma Biomarker Panel to Identify Alzheimer's Disease
- (2012) Maria Björkqvist et al. PLoS One
- Visinin-like protein-1: Diagnostic and prognostic biomarker in Alzheimer disease
- (2011) Rawan Tarawneh et al. ANNALS OF NEUROLOGY
- Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
- (2011) Victor L. Villemagne et al. ANNALS OF NEUROLOGY
- PET amyloid-beta imaging in preclinical Alzheimer's disease
- (2011) Andrei G. Vlassenko et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease
- (2011) Valerio Leoni CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Biomarkers in Alzheimer’s disease
- (2011) Vida Demarin et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Blood serum miRNA: Non-invasive biomarkers for Alzheimer's disease
- (2011) Hirosha Geekiyanage et al. EXPERIMENTAL NEUROLOGY
- Predictive value of APOE- 4 allele for progression from MCI to AD-type dementia: a meta-analysis
- (2011) L. S. Elias-Sonnenschein et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment
- (2011) Ma Fei et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
- (2011) Chor Sang Chim et al. Journal of Translational Medicine
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
- (2011) Stephen Sawcer et al. NATURE
- Plasma apolipoprotein E and Alzheimer disease risk: The AIBL study of aging
- (2011) V. B. Gupta et al. NEUROLOGY
- Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease
- (2010) Madhav Thambisetty et al. ARCHIVES OF GENERAL PSYCHIATRY
- YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
- (2010) Rebecca Craig-Schapiro et al. BIOLOGICAL PSYCHIATRY
- Investigation of 15 of the top candidate genes for late-onset Alzheimer’s disease
- (2010) Olivia Belbin et al. HUMAN GENETICS
- Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease
- (2010) Sudha Seshadri JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
- (2010) Juha O Rinne et al. LANCET NEUROLOGY
- Aβ40 Oligomers Identified as a Potential Biomarker for the Diagnosis of Alzheimer's Disease
- (2010) Carol Man Gao et al. PLoS One
- Identifying and validating biomarkers for Alzheimer's disease
- (2010) Christian Humpel TRENDS IN BIOTECHNOLOGY
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
- (2009) Tero Tapiola et al. ARCHIVES OF NEUROLOGY
- Amyloid- (1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease
- (2009) C. Mulder et al. CLINICAL CHEMISTRY
- Biological Marker Candidates of Alzheimer's Disease in Blood, Plasma, and Serum
- (2009) Philine Schneider et al. CNS Neuroscience & Therapeutics
- O3-02-07: Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways
- (2008) Jill C. Richardson et al. Alzheimers & Dementia
- Visinin-like proteins (VSNLs): interaction partners and emerging functions in signal transduction of a subfamily of neuronal Ca2+-sensor proteins
- (2008) Karl-Heinz Braunewell et al. CELL AND TISSUE RESEARCH
- Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study
- (2008) P Lewczuk et al. MOLECULAR PSYCHIATRY
- IMAGING -AMYLOID BURDEN IN AGING AND DEMENTIA
- (2008) G. Linazasoro et al. NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started